CTOs on the Move

Commonwealth Diagnostics International

www.commdx.com

 
Commonwealth Diagnostics International (CDI), Inc., was founded on the principle that preventative healthcare, including early detection and diagnosis of disease, results in expedited treatment, better patient outcomes, and robust cost savings for the healthcare delivery system. Operating out of a newly constructed laboratory in Salem, MA, CDI is an international diagnostic service provider specializing in innovative diagnostic products that assist physicians and patients with the diagnosis and management of some of the world`s most common sources of digestive distress and functional gastrointestinal disorders, including: hydrogen (H2)/methane (CH4) breath testing for Small Intestinal Bacterial Overgrowth (SIBO) and carbohydrate malabsorption, IBSchek™ for ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.commdx.com
  • 39 Norman Street
    Salem, MA USA 01970
  • Phone: 888.258.5966

Executives

Name Title Contact Details
Nathaniel Allen
 Director of Information Technology Profile

Similar Companies

Sunshine Behavioral Health

Sunshine Behavioral Health is a company that provides high quality addiction and substance abuse treatment, delivered with compassion, integrity and professionalism.

Bluegrass Family Health

Bluegrass Family Health, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Bluegrass Family Health, Inc. is based in Lexington, KY. You can find more information on Bluegrass Family Health, Inc. at www.bgfh.com

Xenon Pharmateuticals

Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling data from the Phase 2b “X-TOLE” study in adult patients with focal epilepsy. We are also proud of the leading-edge science coming out of our discovery labs, with many early-stage research programs underway. In addition to Xenon`s proprietary programs, we have ongoing collaborations with our valued pharmaceutical partners. With a healthy balance sheet to support our growth plans, we continue to build a fully-integrated, premier neuroscience company with strong discovery, development, and commercial operations. Our employees are smart, passionate, dedicated, and driven by their incredibly important work to discover, develop, and deliver new medicines for patients in need. Building and maintaining a respectful, collaborative, inclusive, and productive culture is a priority for us. We are looking for great people who thrive in a fast-paced, dynamic work environment to join our team during this transformative time for Xenon.

Sentry BioPharma Services

Sentry BioPharma Services is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shared Health Svc

Shared Health Svc is a La Crosse, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.